WO2023122663A3 - Protéines effectrices et procédés d'utilisation - Google Patents

Protéines effectrices et procédés d'utilisation Download PDF

Info

Publication number
WO2023122663A3
WO2023122663A3 PCT/US2022/082137 US2022082137W WO2023122663A3 WO 2023122663 A3 WO2023122663 A3 WO 2023122663A3 US 2022082137 W US2022082137 W US 2022082137W WO 2023122663 A3 WO2023122663 A3 WO 2023122663A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
effector proteins
proteins
systems
effector
Prior art date
Application number
PCT/US2022/082137
Other languages
English (en)
Other versions
WO2023122663A2 (fr
Inventor
Lucas Benjamin HARRINGTON
Benjamin Julius RAUCH
Aaron DELOUGHERY
Alexander Richard NECKELMANN
Timothy Robert ABBOTT
William Douglass WRIGHT
Yuxuan Zheng
David Burstein
Dov Arie GERTZ
Tomer PARKIET
Fnu YUNANDA
Original Assignee
Mammoth Biosciences, Inc.
Ramot At Tel-Aviv University Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mammoth Biosciences, Inc., Ramot At Tel-Aviv University Ltd. filed Critical Mammoth Biosciences, Inc.
Publication of WO2023122663A2 publication Critical patent/WO2023122663A2/fr
Publication of WO2023122663A3 publication Critical patent/WO2023122663A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des compositions, des systèmes et des procédés comprenant des protéines effectrices et leurs utilisations. Ces protéines effectrices peuvent être caractérisées en tant que protéines associées à CRISPR (Cas). Des compositions, systèmes et procédés divers de la présente invention peuvent tirer profit des activités de ces protéines effectrices pour la modification, la détection et l'ingénierie d'acides nucléiques.
PCT/US2022/082137 2021-12-23 2022-12-21 Protéines effectrices et procédés d'utilisation WO2023122663A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202163293443P 2021-12-23 2021-12-23
US63/293,443 2021-12-23
US202263321624P 2022-03-18 2022-03-18
US63/321,624 2022-03-18
US202263353469P 2022-06-17 2022-06-17
US63/353,469 2022-06-17

Publications (2)

Publication Number Publication Date
WO2023122663A2 WO2023122663A2 (fr) 2023-06-29
WO2023122663A3 true WO2023122663A3 (fr) 2023-08-03

Family

ID=86903769

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2022/082137 WO2023122663A2 (fr) 2021-12-23 2022-12-21 Protéines effectrices et procédés d'utilisation

Country Status (1)

Country Link
WO (1) WO2023122663A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020168291A1 (fr) * 2019-02-14 2020-08-20 Metagenomi Ip Technologies, Llc Enzymes ayant des domaines ruvc
US20200399697A1 (en) * 2017-11-22 2020-12-24 The Regents Of The University Of California Type v crispr/cas effector proteins for cleaving ssdnas and detecting target dnas
US20210130827A1 (en) * 2019-10-30 2021-05-06 Pairwise Plants Services, Inc. Type v crispr-cas base editors and methods of use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200399697A1 (en) * 2017-11-22 2020-12-24 The Regents Of The University Of California Type v crispr/cas effector proteins for cleaving ssdnas and detecting target dnas
WO2020168291A1 (fr) * 2019-02-14 2020-08-20 Metagenomi Ip Technologies, Llc Enzymes ayant des domaines ruvc
US20210130827A1 (en) * 2019-10-30 2021-05-06 Pairwise Plants Services, Inc. Type v crispr-cas base editors and methods of use thereof

Also Published As

Publication number Publication date
WO2023122663A2 (fr) 2023-06-29

Similar Documents

Publication Publication Date Title
WO2018191715A3 (fr) Polypeptides à activité crispr de type v et leurs usages
WO2023102329A3 (fr) Protéines effectrices et leurs utilisations
WO2018027078A8 (fr) Éditeurs de nucléobases d'adénosine et utilisations associées
WO2017180694A8 (fr) Systèmes d'édition de gènes de molécules de fusion cas9 et leurs procédés d'utilisation
WO2020142754A3 (fr) Améliorations de nucléase programmable ainsi que compositions et méthodes d'amplification et de détection d'acide nucléique
WO2017027423A9 (fr) Compositions de crispr-cas9 manipulées et procédés d'utilisation
WO2002094868A3 (fr) Proteines et acides nucleiques de staphylococcus aureus
WO2021226077A3 (fr) Compositions, systèmes et procédés de génération, d'identification et de caractérisation de domaines effecteurs pour l'activation et le silençage de l'expression génique
WO2015089486A3 (fr) Systèmes, procédés et compositions pour manipulation de séquences avec systèmes crispr-cas fonctionnels optimisés
WO2004022701A3 (fr) Amplification exponentielle d'acides nucleiques au moyen d'agents de croisement specifique favorable
EP2261247A3 (fr) Peptides KDR et vaccins les comportant
WO2015138870A3 (fr) Compositions et méthodes de modification épigénétique ciblée
WO2022051020A3 (fr) Systèmes, procédés et compositions pour effecteurs crispr ciblant l'arn guidés par arn
WO2020030984A3 (fr) Compositions et procédés de modification du génome avec des protéines cas12a
WO2020172631A3 (fr) Protéines de fusion fc d'il-10 non ciblées et ciblées
WO2021211762A3 (fr) Compositions de trem et leurs utilisations
WO2020198174A8 (fr) Édition simultanée de génome multiplex dans une levure
WO2005070828A8 (fr) Acides amines a nanotubes et procedes de preparation de ces acides amines
WO2021108442A3 (fr) Modulateurs de l'activité des polypeptides cas9 et leurs procédés d'utilisation
WO2023122663A3 (fr) Protéines effectrices et procédés d'utilisation
WO2023077095A3 (fr) Protéines effectrices, compositions, systèmes, dispositifs, kits et leurs procédés d'utilisation
WO2023220570A3 (fr) Protéines cas-phi modifiées et leurs utilisations
WO2023220649A3 (fr) Compositions protéiques effectrices et leurs méthodes d'utilisation
WO2024006824A3 (fr) Protéines effectrices, compositions, systèmes et leurs procédés d'utilisation
WO2021077125A3 (fr) Compositions comprenant des peptides courts dérivés de pedf (pdsp) et leurs utilisations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22912698

Country of ref document: EP

Kind code of ref document: A2